leadf
logo-loader
viewFrontier IP Group PLC

Frontier IP's The Vaccine Group to begin animal coronavirus vaccine trials 'imminently'

Frontier IP Group PLC's (LON:FIPP) Neil Crabb tells Proactive London's  Andrew Scott its portfolio company The Vaccine Group is to 'imminently' start trials of its coronavirus vaccine in animals.

Crabb says the idea is to develop an animal inoculation that would prevent the spread of coronavirus from animal to human.

TVG's also working on a number of other animal vaccines including bovine tuberculosis and African Swine Fever.

Quick facts: Frontier IP Group PLC

Price: 69 GBX

AIM:FIPP
Market: AIM
Market Cap: £37.95 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Frontier IP Group PLC named herein, including the promotion by the Company of Frontier IP Group PLC in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Frontier IP Group teams up with University of Cambridge to tackle gum disease

Frontier IP Group PLC's (LON:FIPP) Neil Crabb discusses with Proactive London's Andrew Scott a new joint project between themselves and the University of Cambridge to tackle gum disease. The study's received a £52,891 grant from the National Biofilms Innovation Centre (NBIC). The...

on 19/6/20

2 min read